PARKINSON DISEASE (Disorder)NCT07833150
Balance Performance and Quality of Life in Parkinson's Disease
An observational study of PARKINSON DISEASE (Disorder) and Health Adult Subjects, run by Pamukkale University.
Trial summary
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population. Read more about this study
- Who is it for?
- Ages 20 to 80 yearsHealthy volunteers can take part
- Conditions the study is for
- PARKINSON DISEASE (Disorder), Health Adult Subjects
- How many people
- 40 participants
- Where
- No sites listed yet
- Study dates
- 17 Sep 2026to 10 Oct 2026
- Phase
- Observational
- Are there results?
- Not yet: the study is under way
Key requirements
Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.
- Ages 20 to 80 years
- All sexes
- Healthy volunteers accepted
- Adult, Older adult
Study population: The study population will consist of individuals diagnosed with idiopathic Parkinson's disease who are followed at the Neurology Department of Pamukkale University Hospital and age- and sex-matched healthy individuals recruited from the same geographical region in Denizli, Türkiye.
Who may be able to join
- Willing to participate in the study and providing written informed consent
- Having a diagnosis of idiopathic Parkinson's disease
- Being 20 years of age or older
- Being classified as stage 1-3 according to the Modified Hoehn and Yahr Scale
- Being in the "on" medication state and undergoing assessment one hour after taking antiparkinsonian medication
Who cannot join
- Being a healthy individual matched for age and sex with a participant diagnosed with Parkinson's disease Willing to participate in the study and providing written informed consent Being 20 years of age or older
Trial locations and contacts
No sites are listed yet. Contact the study team or a site near you to ask about taking part.
About this study
Official title: The Relationship Between Performance-Based Balance Tests and Quality of Life in Individuals With Parkinson's Disease
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population.
Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
- Keywords
- Parkinson Disease, Postural Balance, Quality of Life, Balance Assessment, Functional Performance
- Medical subject headings
- Parkinson Disease
What participants receive
What participants receive. In a randomised study each person is assigned to one group by chance.
| Study group | Role | What they receive |
|---|---|---|
| Parkinson's Disease Group | Individuals diagnosed with Parkinson's disease who underwent assessments of balance, functional performance, fear of falling, disease severity, depressive symptoms, and quality of life. No intervention was administered as part of this observational study. | |
| Healthy Control Group | Age- and sex-matched healthy individuals without a diagnosis of Parkinson's disease who underwent balance and functional performance assessments. No intervention was administered as part of this observational study. |
What is being measured
The primary outcome is the main question the study is designed to answer.
Health-Related Quality of Life Assessed by the PDQ-39
Health-related quality of life in individuals with Parkinson's disease will be assessed using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The PDQ-39 Summary Index ranges from 0 to 100, with higher scores indicating poorer health-related quality of life.
Measured: During the single assessment session (approximately 25 minutes)
Timeline
From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.
- First posted22 Sep 2026
- Study start17 Sep 2026 (estimated)
- Primary completion10 Oct 2026 (estimated)
- Study completion10 Oct 2026 (estimated)
Resources
- Official record on ClinicalTrials.govThe registry entry this page is built from, with its full change history.
- Other trials for PARKINSON DISEASE (Disorder)Studies of the same condition, open and under way.
- More trials run by Pamukkale UniversityThe sponsor's other registered studies.
- What the trial phases meanHow a treatment moves from first tests in people to approval.
More details
For doctors and researchers: how the study is designed, who runs it, and its registry IDs.
Study design
- Study type
- Observational
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Enrolment
- 40 participants (estimated)
Sponsor and investigators
- Lead sponsor
- Pamukkale University
- Sponsor type
- University, hospital or other
- Responsible party
- Principal investigator, Büşra ÖZCAN, Pamukkale University
IDs, dates and publications
- ClinicalTrials.gov ID
- NCT07833150
- Sponsor's protocol ID
- E-60116787-020-677981
- Status last verified
- Sep 2026
- First submitted
- 16 Sep 2026
- Last updated
- 22 Sep 2026
- Results posted
- No
- Data monitoring committee
- No
- FDA-regulated drug
- No
- FDA-regulated device
- No
- Individual data sharing
- No
Study at a glance
From the registry record, last updated by the sponsor on 22 Sep 2026. Recruitment status is as the sponsor reported it: confirm with the study team.
- Official title
- The Relationship Between Performance-Based Balance Tests and Quality of Life in Individuals With Parkinson's Disease
- ClinicalTrials.gov ID
- NCT07833150
- Acronym / sponsor ID
- E-60116787-020-677981
- Keywords
- Parkinson Disease, Postural Balance, Quality of Life, Balance Assessment, Functional Performance
- Study type
- Observational
- Recruitment status
- Not yet recruiting
- Enrolment
- 40 participants (estimated)
- Lead sponsor
- Pamukkale UniversityUniversity, hospital or other
- Study start
- 17 Sep 2026 (estimated)
- Primary completion
- 10 Oct 2026 (estimated)
- Study completion
- 10 Oct 2026 (estimated)
- First posted
- 22 Sep 2026 (actual)
- Results
- Not posted in the source record
Clinical summary
The research question as the sponsor registered it. This describes what the study plans to test, not what it found.
This observational study aims to examine the relationship between performance-based balance test results and quality of life in individuals with Parkinson's disease. It also seeks to determine which balance test best explains quality of life in this population.
Balance and functional performance will be assessed using the Six Spot Step Test, 30-Second Chair Stand Test, Timed Up and Go Test, Four Square Step Test, Berg Balance Scale, and 3-Meter Backward Walk Test. Quality of life will be evaluated using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The findings may help clinicians select appropriate assessment methods and develop rehabilitation programs that address the factors associated with quality of life in individuals with Parkinson's disease.
Study design
- Observational model
- Case crossover
- Time perspective
- Cross-sectional
- Number of arms
- 2
| Arm | Type | Receives |
|---|---|---|
| Parkinson's Disease Group | – | –Individuals diagnosed with Parkinson's disease who underwent assessments of balance, functional performance, fear of falling, disease severity, depressive symptoms, and quality of life. No intervention was administered as part of this observational study. |
| Healthy Control Group | – | –Age- and sex-matched healthy individuals without a diagnosis of Parkinson's disease who underwent balance and functional performance assessments. No intervention was administered as part of this observational study. |
Who may qualify
- Ages
- 20 to 80 years
- Sex
- All
- Healthy volunteers
- Accepted
- Age groups
- Adult, Older adult
- Study population
- The study population will consist of individuals diagnosed with idiopathic Parkinson's disease who are followed at the Neurology Department of Pamukkale University Hospital and age- and sex-matched healthy individuals recruited from the same geographical region in Denizli, Türkiye.
Key inclusion criteria (5 listed)
- Willing to participate in the study and providing written informed consent
- Having a diagnosis of idiopathic Parkinson's disease
- Being 20 years of age or older
- Being classified as stage 1-3 according to the Modified Hoehn and Yahr Scale
- Being in the "on" medication state and undergoing assessment one hour after taking antiparkinsonian medication
Key exclusion criteria (1 listed)
- Being a healthy individual matched for age and sex with a participant diagnosed with Parkinson's disease Willing to participate in the study and providing written informed consent Being 20 years of age or older
Eligibility is decided by the study team after screening; this overview does not establish that a patient qualifies. Full inclusion and exclusion criteria.
Primary outcome
Health-Related Quality of Life Assessed by the PDQ-39
Time frame: During the single assessment session (approximately 25 minutes)
Health-related quality of life in individuals with Parkinson's disease will be assessed using the 39-item Parkinson's Disease Questionnaire (PDQ-39). The PDQ-39 Summary Index ranges from 0 to 100, with higher scores indicating poorer health-related quality of life.
Results and safety
This study is still under way. Results are not available in the source record yet.
Research links
- Official record on ClinicalTrials.govLast updated by the sponsor 22 Sep 2026.
- Individual participant dataSharing planned: No
Related trials for PARKINSON DISEASE (Disorder)
Not yet recruitingPhase 1/2
STAR0602 With Nivolumab in Non Small Cell Lung Cancer and in Metastatic Castrate-Resistant Prostate Cancer, and STAR0602 Alone in Thymic Carcinoma
NSCLC, Non-Small Cell Lung Cancer
Enrolling by invitationObservational study
Early Molecular Biomarkers for Differentiating Parkinsonian Syndromes
PARKINSON DISEASE (Disorder), Atypical Parkinsonism
RecruitingPhase 3
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
Cervical Cancer
Active, not recruitingPhase 1/2
Clinical Safety and Efficacy of Umbilical Cord Mesenchymal Stromal Cells-derived Exosomes in Patients With Parkinson's Disease
Parkinson Disease (PD)
Active, not recruitingObservational study
Adaptive DBS to Offset STN Dysregulation During Exercise in PD
Parkinson Disease
Referral and contact
AzTrials does not enrol participants or take referrals. Contact the study team or a site listed below; they decide who can take part.
Questions about this trial
What is this clinical trial studying?
An observational study of PARKINSON DISEASE (Disorder) and Health Adult Subjects, run by Pamukkale University.
The full registered description is in the About this study section and the official record.
Who may be eligible to take part?
The sponsor lists 5 inclusion and 1 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.
Is this clinical trial currently recruiting?
The record says: opening soon, as of the sponsor's last update on 22 Sep 2026. Status can change between updates, so confirm with the study contact before making plans.
What are the possible benefits and risks?
They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.
Are results available for this study?
This study is still under way. Results are not available in the source record yet.
How can a doctor refer a patient or contact the research team?
Contact Büşra ÖZCAN, MSc (+905533514349, busra6873@gmail.com), or a site near the patient. AzTrials does not enrol participants or take referrals.
What does the primary outcome measure?
Health-Related Quality of Life Assessed by the PDQ-39 (time frame: During the single assessment session (approximately 25 minutes)). It is what the study was designed to measure, not a finding.
Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?
No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.
How often is this information updated?
AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 22 Sep 2026.